𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection

✍ Scribed by H.L. Zaaijer; P. Torres; A. Ontañón; L. González Ponte; M.H.G.M. Koppelman; P.N. Lelie; F.J.van Hemert; H.J. Boot


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
100 KB
Volume
80
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Occult hepatitis B virus (HBV) infection is characterized by the presence of HBV DNA while the HBV surface antigen (HBsAg) remains undetectable. The HBV genomes in five asymptomatic blood donors with occult HBV infection and low viremia (<10 to 1,000 HBV DNA copies/mL, genotype D) were studied. An unusually large number of amino acid mutations was present in the immunodominant a‐determinant of HBsAg (respectively 3, 6, 7, 10, and 10 mutations). Comparison of the HBV genomes in two donors to a consensus HBV genotype D sequence showed a most prominent hotspot of genetic variation in HBV nucleotides 480–570, encoding the HBsAg a‐determinant. The phylogenetic comparison of separate donor HBV genes to the HBV genes of 11 reference strains (genotypes A–H) showed the donor HBV surface genes to form an outgroup, while the HBV polymerase, core and X genes closely cluster with the HBV genotype D reference strain. Maybe the HBV strains in this study represent a natural end‐stage of seemingly cleared HBV infection, in which HBV maintains a low level of possibly non‐infectious replication, after sacrificing its immunologically offending surface antigen, thus avoiding final clearance by the immune system. J. Med. Virol. 80:1344–1349, 2008. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Role of surface promoter mutations in he
✍ Sonali Sengupta; Shagufta Rehman; Hemlata Durgapal; Subrat Kumar Acharya; Subrat 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 256 KB

## Abstract The production, secretion, and localization of surface proteins of hepatitis B virus (HBV) and the ratio of large to small surface protein S was studied in HepG2 cells transfected with the wild‐type and mutant pre‐S1 and pre‐S2/S promoters of HBV molecular clones 313.1 (GenBank accessio

Molecular and serological evaluation of
✍ Cristina Gutiérrez; Marisol Devesa; Carmen Luisa Loureiro; Graciela León; Ferdin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Abstract Surface antigen negative hepatitis B virus (HBV) infection was evaluated in Venezuela, by molecular characterization of blood samples positive for antibodies to core antigen (anti‐HBc) and negative for surface antigen (HBsAg) in blood donors (residual infections). HBV DNA was found in 1

Association of concurrent hepatitis B su
✍ Ji Sun Jang; Hyoung Su Kim; Ha Jung Kim; Woon Geon Shin; Kyung Ho Kim; Jin Heon 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

## Abstract Antibody to hepatitis B surface antigen (HBsAg) (anti‐HBs) can exist in patients with chronic hepatitis B virus (HBV) infection. To date, little is known about the association of concurrent HBsAg and anti‐HBs (concurrent HBsAg/ anti‐HBs) with hepatocellular carcinoma (HCC). The aim of t

Immunoglobulin and hepatitis B surface a
✍ Jung-Fa Tsai; Harold S. Margolis; Howard A. Fields; Omana V. Nainan; Wen Yu Chan 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 483 KB 👁 1 views

## Abstract IgM, IgG, and HBsAg containing circulating immune complexes (CIC) were determined, by conglutinin (K) and C1q assays, for assessing the role of CIC in hepatitis delta virus (HDV) infection in 54 HBsAg‐negative controls and 85 HBsAg‐positive patients with chronic hepatitis. The prevalenc

PreS deletion mutations of hepatitis B v
✍ Xiangyan Huang; Yanghua Qin; Peng Zhang; Gusheng Tang; Qingfen Shi; Jun Xu; Fali 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB 👁 2 views

Hepatitis B surface antigen (HBsAg) and anti-HBs antibodies (anti-HBs) may coexist in certain chronic hepatitis B (CHB) patients. This study was designed to further explore the relationship between this coexistence and hepatitis B Virus (HBV) preS deletions. Sera of 28 patients carrying both HBsAg a